Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types von Yu, K., Chen, B., Aran, D., Charalel, J., Yau, C., Wolf, D. M., van ‘t Veer, L. J., Butte, A. J., Goldstein, T., Sirota, M.

Volltext

Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer von Lopes Cardozo, J. M. N., Schmidt, M. K., van ’t Veer, L. J., Cardoso, F., Poncet, C., Rutgers, E. J. T., Drukker, C. A.

Volltext

Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial von Viale, G., de Snoo, F. A., Slaets, L., Bogaerts, J., van ’t Veer, L., Rutgers, E. J., Piccart-Gebhart, M. J., Stork-Sloots, L., Glas, A., Russo, L., Dell’Orto, P., Tryfonidis, K., Litière, S., Cardoso, F.

Volltext

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age von Mook, S., Schmidt, M.K., Weigelt, B., Kreike, B., Eekhout, I., van de Vijver, M.J., Glas, A.M., Floore, A., Rutgers, E.J.T., van ‘t Veer, L.J.

Volltext

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival von Magbanua, M.J.M., Swigart, L.B., Wu, H.-T., Hirst, G.L., Yau, C., Wolf, D.M., Tin, A., Salari, R., Shchegrova, S., Pawar, H., Delson, A.L., DeMichele, A., Liu, M.C., Chien, A.J., Tripathy, D., Asare, S., Lin, C.-H.J., Billings, P., Aleshin, A., Sethi, H., Louie, M., Zimmermann, B., Esserman, L.J., van ‘t Veer, L.J.

Volltext

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study von Drukker, C.A., Bueno‐de‐Mesquita, J.M., Retèl, V.P., Harten, W.H., Tinteren, H., Wesseling, J., Roumen, R.M.H., Knauer, M., Veer, L.J., Sonke, G.S., Rutgers, E.J.T., Vijver, M.J., Linn, S.C.

Volltext

Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial von Lopes Cardozo, J.M.N., Byng, D., Drukker, C.A., Schmidt, M.K., Binuya, M.A., van ’t Veer, L.J., Cardoso, F., Piccart, M., Smorenburg, C.H., Poncet, C., Rutgers, E.J.T.

Volltext

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis von Drukker, C. A., Elias, S. G., Nijenhuis, M. V., Wesseling, J., Bartelink, H., Elkhuizen, P., Fowble, B., Whitworth, P. W., Patel, R. R., de Snoo, F. A., van ’t Veer, L. J., Beitsch, P. D., Rutgers, E. J. Th

Volltext

Molecular alterations associated with liver metastases development in colorectal cancer patients von Bruin, S C, He, Y, Mikolajewska-Hanclich, I, Liefers, G-J, Klijn, C, Vincent, A, Verwaal, V J, de Groot, K A, Morreau, H, van Velthuysen, M-L F, Tollenaar, R A E M, van ‘t Veer, L J

Volltext

Expression of a novel lacrimal gland gene lacritin in human breast tissues von WEIGELT, B, BOSMA, A. J, VAN'T VEER, L. J

Volltext

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature von Knauer, M, Cardoso, F, Wesseling, J, Bedard, P L, Linn, S C, Rutgers, E J T, van 't Veer, L J

Volltext

E2F-5, a new E2F family member that interacts with p130 in vivo von Hijmans, E. Marielle, Voorhoeve, P. Mathijs, Beijersbergen, Roderick L., van 't Veer, Laura J., Bernards, René

Volltext

Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers von GODSCHALK, R. W. L, MAAS, L. M, VAN ZANDWIJK, N, VAN'T VEER, L. J, BREEDIJK, A, BORM, P. J. A, VERHAERT, J, KLEINJANS, J. C. S, VAN SCHOOTEN, F. J

Volltext

A breast cancer gene classification for indolent disease von Delahaye, L, Drukker, C, Dreezen, C, Witteveen, A, Chan, B, Snel, M, Beumer, I, Neijenhuis, S, van “t Veer, L, Glas, A

Volltext

Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancer von Kok, M, Koornstra, R.H, Mook, S, Hauptmann, M, Fles, R, Jansen, M.P, Berns, E.M, Linn, S.C, Van 't Veer, L.J

Volltext

4LBA RNA, protein or gene? ER, PgR and HER2 by local and central pathology review, and microarray readout (by TargetPrint) in the EORTC 10041/BIG 03-04 MINDACT trial von Cardoso, F, Slaets, L, Russo, L, Bogaerts, J, van 't Veer, L, Rutgers, E, Piccart-Gebhart, M.J, de Snoo, F.A, Viale, G

Volltext

Abstract S5-02: Veliparib/carboplatin plus standard neoadjuvant therapy for high-risk breast cancer: First efficacy results from the I-SPY 2 TRIAL von Rugo, HS, Olopade, O, DeMichele, A, van 't Veer, L, Buxton, M, Hylton, N, Yee, D, Chien, AJ, Wallace, A, Lyandres, J, Davis, S, Sanil, A, Berry, D, Esserman, L

Volltext

Adjuvant treatment in colorectal cancer von Taal, B G, van Tinteren, H, van t Veer, L

Volltext

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer von Rugo, Hope S, Olopade, Olufunmilayo I, DeMichele, Angela, Yau, Christina, van ’t Veer, Laura J, Buxton, Meredith B, Hogarth, Michael, Hylton, Nola M, Paoloni, Melissa, Perlmutter, Jane, Symmans, W. Fraser, Yee, Douglas, Chien, A. Jo, Wallace, Anne M, Kaplan, Henry G, Boughey, Judy C, Haddad, Tufia C, Albain, Kathy S, Liu, Minetta C, Isaacs, Claudine, Khan, Qamar J, Lang, Julie E, Viscusi, Rebecca K, Pusztai, Lajos, Moulder, Stacy L, Chui, Stephen Y, Kemmer, Kathleen A, Elias, Anthony D, Edmiston, Kirsten K, Euhus, David M, Haley, Barbara B, Nanda, Rita, Northfelt, Donald W, Tripathy, Debasish, Wood, William C, Ewing, Cheryl, Schwab, Richard, Lyandres, Julia, Davis, Sarah E, Hirst, Gillian L, Sanil, Ashish, Berry, Donald A, Esserman, Laura J

Volltext

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients von Weigelt, B, Bosma, A J, Hart, A A M, Rodenhuis, S, van't Veer, L J

Volltext